Insiders Were Right: IDXX Makes New 52-Week High

In trading on Monday, shares of Idexx Laboratories, Inc. ( IDXX) touched a new 52-week high of $129.47/share. That's a 58.72% rise, or $47.9 per share from the 52-week low of $81.57 set back on 05/30/2013. That means at today's intraday high, any investor who purchased IDXX stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, IDXX has seen 3 different instances of insiders buying over the trailing six month period.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
11/04/2013 M. Anne Szostak Director 1,000 $108.24 $108,240.00
11/22/2013 Sophie V. Vandebroek Director 1,000 $107.84 $107,840.00
12/12/2013 Robert J. Murray Director 500 $102.31 $51,155.00
02/20/2014 M. Anne Szostak Director 2,000 $126.71 $253,425.60

The chart below shows where IDXX has traded over the past year, with the 50-day and 200-day moving averages included.

If you liked this article you might like

Arconic, Idexx Laboratories, AbbVie: 'Mad Money' Lightning Round

Don't Get Shaken Out of Good Stocks: Cramer's 'Mad Money' Recap (Wed 9/13/17)

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)

IDEXX Laboratories: Cramer's Top Takeaways

'I Love the Down-and-Outers': Cramer's 'Mad Money' Recap (Thursday 7/13/17)